期刊文献+

欧盟新法规下的药物警戒制度简介 被引量:22

Introduction of European Union Pharmacovigilance System facing New Regulation
下载PDF
导出
摘要 通过对于欧盟药物警戒法规修订情况的介绍,进一步了解欧盟药物警戒制度框架的组成,并且清晰了欧盟药物警戒系统和质量体系、药物警戒系统主文件、药物警戒检查、风险管理系统等制度形式的具体内容,为完善和发展我国药品不良反应报告和监测体系提供借鉴和参考。 By introducing the revision of European Union(EU) Pharmocovigilance regulation, it helped to know the structure of EU Pharmacovigilance system better. And it also clearly showed the contents of the system, such as Pharmacovigilance Systems and their Quality Systems, Pharrnacovigilance System Master File, Pharmacovigilance Inspections, Risk Management Systems. It provided the example and reference for perfecting and developing Adverse Drug Reaction Reporting and Monitoring System of China.
出处 《中国药物警戒》 2012年第11期662-665,共4页 Chinese Journal of Pharmacovigilance
关键词 欧盟 新法规 药物警戒 制度 European Union new regulation pharmacovigilance system
  • 相关文献

参考文献20

  • 1European Commission. The EU pharmacovigilance system[EB/OL]. http://ec.europaeu/health/human-use/pharmacovigilance/index_en. htm#geninf( 2012-09-16 ).
  • 2Peter Arlett. New Pharmacovigilance legislation and focus on post-authorisation studies (2010-11-29)[EB/OL].www.diahome. org/.../24003/session%203_peter%20arlett.pdf (2012-9-16).
  • 3European Medicines Agency. 2010 pharmacovigilance legislation [EB/OL].http://www.ema.europa.eu/ema/index.j sp curl=pages/ regulation/general/general_content_000492.j sp&mid=WC0b01 ac 058033e8ad (2012-9-16).
  • 4European Medicines Agency. Commission Implementing Regula- tion (EU) No 520/2012 (2012-6-19)[EB/OL]. http://eurx.europa. eu/LexUriServ/LexUriServ.do?uri=OJ:L:2012:159:0005:0025: EN:PDF (2012-9-16).
  • 5European Medicines Agency. Good Pharmacovigilance Practices [ EB/OL ]. http://www, ema. europa, eu/ema/index .j sp curl=pages/ regulation/document_listing/document_listing_000345. j sp&mid=WC0b01 ac058058f32c ( 2012-9-16 ).
  • 6European Medicines Agency. GVP Module I Pharmacovigilance Systems and their Quality Systems (2012-6-22) [EB/OL].http:// www.ema.europa.eu/docs/en_GB/document_library/Scientif- ic_guideline/2012/06/WC500129132.pdf( 2012-09-17 ).
  • 7European Medicines Agency. GVP Module II Pharmacovigilance System Master File(2012-6-22 ) [EB/OL].http://www.ema.europa. eu/docs/en GB/document_library/Scientific_guideline/2012/06/ WCS00129133.pdf(2012-09-17).
  • 8European Medicines Agency. GVP Module III Pharmacovigilance Inspections( 2012-6-22 ) [EB/OL] .http://www.ema.europa.eu/docs/en_ GB/document_library/Scientific_guideline/2012/06/WC500129243. pdf(2012-09-17).
  • 9董铎,孙利华,杨晓茹.欧盟药物警戒检查制度简介[J].中国新药杂志,2012,21(8):832-835. 被引量:5
  • 10European Medicines Agency. GVP Module V- Risk Management Systems( 2012-6-22 )[EB/OL].http://www.ema.europa.eu/docs/en_ GB/document_library/Scientific_guideline/2012/06/WC500129134. pdf(2012-9-18).

二级参考文献25

  • 1邓培媛,李群娜,朱玉珍,裴振峨,张俊,翟伟,张京航,闫伟,詹思延.葛根素注射剂不良反应及其影响因素分析[J].药物流行病学杂志,2005,14(1):14-17. 被引量:58
  • 2ICH.Clinical Safety Data Management:Periodic SafetyUpdate Reports for Marketed Drugs E2C(R1)(Nov.2005)[EB/OL].[2011-09-13].http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E2C/Step4/E2C_R1__Guideline.pdf.
  • 3EMA.VOLUME9A of The Rules Governing Medicinal P r o d u c t s i n t h e E u r o p e a n U n i o n,G u i d e l i n e s o n Pharmacovigilance for Medicinal Products for Human Use(Sept.2008)[EB/OL].[2011-09-16].http://ec.europa.eu/health/files/eudralex/vol-9/pdf/vol9a_09-2008_en.pdf.
  • 4FDA.Guidance for Industry Addendum to E2C Clinical Safety Data Management:Periodic Safety Update Reports for Marketed Drugs(Feb.2004)[EB/OL].[2011-09-16].http://www.fda.gov/downloads/Drugs/GuidanceCompliance RegulatoryInformation/Guidances/UCM073105.pdf.
  • 5Mann RD,Andrews EB.Pharmacovigilance[M].2nd ed,England:John Wiley&Sons,Ltm,2007:63.
  • 6卫生部.药品不良反应报告和监测管理办法(2011-05-04)[EB/OL].[2011-09-16].http://www.sda.gov.cn/WS01/CL0053/62621.html.
  • 7Klepper MJ.The periodic safety update report as a pharmacovigilance tool[J].Drug Safety,2004,27(8):569-578.
  • 8Edwards BD,Furlan G.How to apply the human factor to periodic safety update reports[J].Drug Safety,2010,33(10):815.
  • 9国家食品药品监督管理局药品评价中心.《药品重点监测指南》座谈会在京召开[EB/OL].[2011-12-20].http://www.cdr.gov.cn/xwdt/201110/t20111008_4754.html
  • 10European Commission.Volume 9A of the rules governingmedicinal products in the European Union–guidelineson pharmacovigilance for medicinal products for humanuse(2008-9)[EB/OL].[2011-10-2].http://ec.europa.eu/health/files/eudralex/vol-9/pdf/vol9a_09-2008_en.pdf

共引文献37

同被引文献170

引证文献22

二级引证文献124

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部